Endonovo Therapeutics, Inc. (ENDV) has 12 identified peers for comparison in the Healthcare sector. Peers include BIOAF, BITRF, BOLT, BPTH, CING, CMRA and others.
ENDV has a market capitalization of $31.88K, compared to an average peer market cap of $39.43M. ENDV is notably smaller than its average peer.